State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, China.
Department of Chemistry, Duke University, Durham, NC, United States.
Front Cell Infect Microbiol. 2018 Jun 8;8:192. doi: 10.3389/fcimb.2018.00192. eCollection 2018.
Lipid A is an essential basal component of lipopolysaccharide of most Gram-negative bacteria. Inhibitors targeting LpxC, a conserved enzyme in lipid A biosynthesis, are antibiotic candidates against Gram-negative pathogens. Here we report the characterization of the role of lipid A in growth in axenic media, monkey kidney cells (BGMK and Vero), and macrophage-like THP-1 cells by using a potent LpxC inhibitor -LPC-011. We first determined the susceptibility of LpxC to LPC-011 in a surrogate model. In , the minimum inhibitory concentration (MIC) of LPC-011 against LpxC is < 0.05 μg/mL, a value lower than the inhibitor's MIC against LpxC. Considering the inhibitor's problematic pharmacokinetic properties and 's culturing time up to 7 days, the stability of LPC-011 in cell cultures was assessed. We found that regularly changing inhibitor-containing media was required for sustained inhibition of LpxC in cells. Under inhibitor treatment, has reduced growth yields in axenic media and during replication in non-phagocytic cells, and has a reduced number of productive vacuoles in such cells. Inhibiting lipid A biosynthesis in by the inhibitor was shown in a phase II strain transformed with chlamydial . This exogenous KdtA enzyme modifies lipid A with an α-Kdo-(2 → 8)-α-Kdo epitope that can be detected by anti- genus antibodies. In inhibitor-treated THP-1 cells, shows severe growth defects characterized by poor vacuole formation and low growth yields. progenies prepared from inhibitor-treated cells retain the capability of normally infecting all tested cells in the absence of the inhibitor, which suggests a dispensable role of lipid A for infection and early vacuole development. In conclusion, our data suggest that lipid A has significance for optimal development of -containing vacuoles, and for robust multiplication of in macrophage-like THP-1 cells. Unlike many bacteria, replication in axenic media and non-phagocytic cells was less dependent on normal lipid A biosynthesis.
脂 A 是大多数革兰氏阴性菌脂多糖的基本基本组成部分。针对脂 A 生物合成中保守酶 LpxC 的抑制剂是针对革兰氏阴性病原体的抗生素候选物。在这里,我们通过使用有效的 LpxC 抑制剂 -LPC-011 来报告脂 A 在无细胞培养基、猴肾细胞(BGMK 和 Vero)和巨噬细胞样 THP-1 细胞中的生长中的作用特征。我们首先在替代模型中确定了 LpxC 对 LPC-011 的敏感性。在该模型中,LPC-011 对 LpxC 的最小抑菌浓度(MIC)<0.05 μg/mL,低于抑制剂对 LpxC 的 MIC。考虑到抑制剂的药代动力学性质存在问题,且 的培养时间长达 7 天,因此评估了细胞培养物中 LPC-011 的稳定性。我们发现,需要定期更换含抑制剂的培养基才能在细胞中持续抑制 LpxC。在抑制剂处理下,在无细胞培养基中的生长产率降低,在非吞噬细胞中的复制能力降低,并且在这些细胞中的有功能的空泡数量减少。通过抑制剂抑制 中的脂 A 生物合成,在转化为衣原体的 II 期菌株中显示出来。这种外源 KdtA 酶用可被抗属抗体检测到的 α-Kdo-(2 → 8)-α-Kdo 表位修饰 脂 A。在抑制剂处理的 THP-1 细胞中, 显示出严重的生长缺陷,其特征为空泡形成不良和生长产率低。从抑制剂处理的细胞中制备的 后代在没有抑制剂的情况下保留了正常感染所有测试细胞的能力,这表明脂 A 对于感染和早期空泡发育不是必需的。总之,我们的数据表明,脂 A 对含 的空泡的最佳发育以及在巨噬细胞样 THP-1 细胞中 的稳健繁殖具有重要意义。与许多细菌不同,在无细胞培养基和非吞噬细胞中, 的复制对正常脂 A 生物合成的依赖性较低。